The online version of this article (doi:10.1186/1477-7819-10-71) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
MLC and ST drafted the manuscript, contributed to conception, manuscript and design preparation, and conducted a literature search. MLC, ST, FM, VR, and LB performed and analyzed PET and CT images. LL, GT, and FM contributed to acquisition of data and obtained images used in the manuscript. VR participated in the design of the study. LB and AG critically revised the manuscript. All authors read and approved the final manuscript.
18F-fluoro-deoxy-glucose (18 F-FDG) positron emission tomography integrated/combined with computed tomography (PET-CT) provides the best diagnostic results in the metabolic characterization of undetermined solid pulmonary nodules. The diagnostic performance of 18 F-FDG is similar for nodules measuring at least 1 cm and for larger masses, but few data exist for nodules smaller than 1 cm.
We report five cases of oncologic patients showing focal lung 18 F-FDG uptake on PET-CT in nodules smaller than 1 cm. We also discuss the most common causes of 18 F-FDG false-positive and false-negative results in the pulmonary parenchyma.
In patient 1, contrast-enhanced CT performed 10 days before PET-CT did not show any abnormality in the site of uptake; in patient 2, high-resolution CT performed 1 month after PET showed a bronchiole filled with dense material interpreted as a mucoid impaction; in patient 3, contrast-enhanced CT performed 15 days before PET-CT did not identify any nodules; in patients 4 and 5, contrast-enhanced CT revealed a nodule smaller than 1 cm which could not be characterized. The 18 F-FDG uptake at follow-up confirmed the malignant nature of pulmonary nodules smaller than 1 cm which were undetectable, misinterpreted, not recognized or undetermined at contrast-enhanced CT.
In all five oncologic patients, 18 F-FDG was able to metabolically characterize as malignant those nodules smaller than 1 cm, underlining that: 18 F-FDG uptake is not only a function of tumor size but it is strongly related to the tumor biology; functional alterations may precede morphologic abnormalities. In the oncologic population, especially in higher-risk patients, PET can be performed even when the nodules are smaller than 1 cm, because it might give an earlier characterization and, sometimes, could guide in the identification of alterations missed on CT.
Authors’ original file for figure 112957_2011_1069_MOESM1_ESM.tiff
Authors’ original file for figure 212957_2011_1069_MOESM2_ESM.tiff
Authors’ original file for figure 312957_2011_1069_MOESM3_ESM.tiff
Authors’ original file for figure 412957_2011_1069_MOESM4_ESM.tiff
Authors’ original file for figure 512957_2011_1069_MOESM5_ESM.tiff
Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, Czernin J, Schiepers C: Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med. 2007, 48: 214-220. PubMed
Lillington GA: Management of solitary pulmonary nodules. Dis Mon. 1991, 5: 271-318.
Yeong JJ, Chin AY, Kyung SL: Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. AJR. 2007, 188: 57-68. 10.2214/AJR.05.2131. CrossRef
Reinhardt MJ, Wiethoelter N, Matthies A, Joe AY, Strunk H, Jaeger U, Biersack H-J: PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging. 2006, 33: 134-139. 10.1007/s00259-005-1901-1. CrossRefPubMed
Divisi D, Di Tommaso S, Di Leonardo G, Brianzoni E, De Vico A, Crisci R: 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Thorac Cardiovasc Surg. 2010, 58: 422-426. 10.1055/s-0030-1249945. CrossRefPubMed
Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, Taniguchi M, Tonami H, Okimura T, Yamamoto I: Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med. 1998, 39: 1016-1020. PubMed
Nehmeh SA, Erdi YE, Ling CC, Rosenzweig KE, Schoder H, Larson SM, Macapinlac HA, Squire OD, Humm JL: Effect of respiratory gating on quantifying pet images of lung cancer. J Nucl Med. 2002, 43: 876-881. PubMed
Bakheet SM, Powe J: Benign causes of 18-fdg uptake on whole body imaging. Semin Nucl Med. 1998, XXVIII: 352-358.
Wormanns D, Diederich S: Characterization of small pulmonary nodules by CT. Eur Radiol. 2004, 14: 1380-1391. PubMed
Feine U, Lietzenmayer R, Hanke JP, Held J, Wohrle H, Muller-Schauenburg W: Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med. 1996, 37: 1468-1472. PubMed
- 18 F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports
Maria Lucia Calcagni
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II